Harbor Capital Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-90,267
Closed -$1.34M 747
2024
Q1
$1.34M Buy
90,267
+17,534
+24% +$204K 0.17% 154
2023
Q4
$591K Buy
72,733
+7,870
+12% +$41.2K 0.11% 220
2023
Q3
$295K Buy
64,863
+8,522
+15% +$55.6K 0.06% 310
2023
Q2
$397K Buy
56,341
+5,172
+10% +$37K 0.08% 286
2023
Q1
$313K Buy
51,169
+14,548
+40% +$100K 0.09% 184
2022
Q4
$234K Sell
36,621
-780
-2% -$6.09K 0.23% 78
2022
Q3
$358K Sell
37,401
-2,033
-5% -$23.4K 0.33% 70
2022
Q2
$435K Sell
39,434
-2,749
-7% -$36K 0.33% 72
2022
Q1
$702K Sell
42,183
-9,357
-18% -$145K 0.33% 72
2021
Q4
$984K Buy
+51,540
New +$1.13M 0.36% 75

Other funds holding IOVA